Cargando…

Transdermal estradiol in castrate and chemotherapy resistant prostate cancer

BACKGROUND: Given prior studies demonstrating the marked clinical activity of oral estrogens in prostate cancer, more recent data demonstrating the safety of transdermal estradiol, and the renewed interest in targeting testosterone metabolism and androgen receptor pathways, we report the results of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stein, Mark, Goodin, Susan, Doyle-Lindrud, Susan, Silberberg, Jeffrey, Kane, Michael, Metzger, Dorinda, Eddy, Simantini, Shih, Weichung, DiPaola, Robert S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2012
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560819/ https://www.ncbi.nlm.nih.gov/pubmed/22460098 http://dx.doi.org/10.12659/MSM.882626

Ejemplares similares

Moving towards universal health coverage: advanced practice nurse competencies
por: Honig, Judy, et al.
Publicado: (2019)

Estradiol suppresses tissue androgens and prostate cancer growth in castration resistant prostate cancer
por: Montgomery, Bruce, et al.
Publicado: (2010)

Efficacy of transdermal flunixin in mitigating castration pain in piglets
por: Lopez-Soriano, Magdiel, et al.
Publicado: (2022)

Achieving Physiologic 17-ẞ-Estradiol Levels in Transgender Females on Estradiol Transdermal Patches and Optimal Dosing
por: Trovato, Alexa, et al.
Publicado: (2021)

Chemotherapy options in castration-resistant prostate cancer
por: Teply, Benjamin A., et al.
Publicado: (2016)

Physiologic Transdermal Estradiol Replacement Mimics Effects of Endogenous Estrogen on Bone Outcomes in Hypoestrogenic Women with Anorexia Nervosa
por: Singhal, Vibha, et al.
Publicado: (2022)

Toward Maximizing Immunotherapy in Metastatic Castration-Resistant Prostate Cancer – Rationale for Combinatorial Approaches Using Chemotherapy
por: Slovin, Susan R.
Publicado: (2012)

Combination of α-Tomatine and Curcumin Inhibits Growth and Induces Apoptosis in Human Prostate Cancer Cells
por: Huang, Huarong, et al.
Publicado: (2015)

Enhanced Skin Permeation of Estradiol by Dimethyl Sulfoxide Containing Transdermal Patches
por: Otterbach, Anna, et al.
Publicado: (2021)

Assessment of Estradiol-Induced Gonadotropin Surge Generation: Preliminary Results From a Protocol of Graded Transdermal Estradiol Dosing
por: McCartney, Christopher R, et al.
Publicado: (2021)

Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition
por: Kantarci, Kejal, et al.
Publicado: (2016)

Role of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate Cancer
por: Lohiya, Vipin, et al.
Publicado: (2016)

Evaluation of the pharmacokinetics and efficacy of transdermal flunixin for pain mitigation following castration in goats
por: Graves, Meggan T, et al.
Publicado: (2020)

A randomized phase II trial of mitoxantrone, estramustine and vinorelbine or bcl-2 modulation with 13-cis retinoic acid, interferon and paclitaxel in patients with metastatic castrate-resistant prostate cancer: ECOG 3899
por: DiPaola, Robert S, et al.
Publicado: (2010)

Carboplatin-etoposide combination chemotherapy in metastatic castration-resistant prostate cancer: A retrospective study
por: CAUBET, MATTHIEU, et al.
Publicado: (2015)

Inhibitory Effect of a γ-Tocopherol-Rich Mixture of Tocopherols on the Formation and Growth of LNCaP Prostate Tumors in Immunodeficient Mice
por: Zheng, Xi, et al.
Publicado: (2011)

Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer
por: Recine, Federica, et al.
Publicado: (2015)

A Comparison of the Effects of Transdermal Estradiol and Estradiol Valerate on Endometrial Receptivity in Frozen-thawed Embryo Transfer Cycles: A Randomized Clinical Trial
por: Davar, Robab, et al.
Publicado: (2016)

The role of transdermal estrogen sprays and estradiol topical emulsion in the management of menopause-associated vasomotor symptoms
por: Egras, Amy M, et al.
Publicado: (2010)

Castration for Prostatic Hypertrophy
Publicado: (1899)

Population-based study on use of chemotherapy in men with castration resistant prostate cancer
por: Lissbrant, Ingela Franck, et al.
Publicado: (2013)

Metabolic Reprogramming of Castration-Resistant Prostate Cancer Cells as a Response to Chemotherapy
por: Petrella, Greta, et al.
Publicado: (2022)

Budget Impact of Enzalutamide for Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer
por: Bui, Cat N., et al.
Publicado: (2016)

Potent Inhibitory Effect of δ-Tocopherol on Prostate Cancer Cells Cultured in Vitro and Grown As Xenograft Tumors in Vivo
por: Huang, Huarong, et al.
Publicado: (2014)

Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer
por: Stein, Mark N, et al.
Publicado: (2014)

17‐α estradiol ameliorates age‐associated sarcopenia and improves late‐life physical function in male mice but not in females or castrated males
por: Garratt, Michael, et al.
Publicado: (2019)

Prostatic Neoplasia in the Intact and Castrated Dog: How Dangerous is Castration?
por: Schrank, Magdalena, et al.
Publicado: (2020)

Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer
por: Lin, H-M, et al.
Publicado: (2014)

Importance of cycles of chemotherapy and postdocetaxel novel therapies in metastatic castration-resistant prostate cancer
por: Poon, Darren M.C., et al.
Publicado: (2015)

Reinduction of Hormone Sensitivity to Goserelin following Chemotherapy with Vinorelbine in Castration-Resistant Prostate Cancer
por: Grenader, Tal, et al.
Publicado: (2010)

Dynamic changes in gene alterations during chemotherapy in metastatic castrate resistant prostate cancer
por: Tan, Winston, et al.
Publicado: (2022)

The effect of chemotherapy on the exposure–response relation of abiraterone in metastatic castration‐resistant prostate cancer
por: Boerrigter, Emmy, et al.
Publicado: (2021)

Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells
por: Bansal, Nitu, et al.
Publicado: (2015)

Pretreatment of normal responders in fresh in vitro fertilization cycles: A comparison of transdermal estradiol and oral contraceptive pills
por: Pereira, Nigel, et al.
Publicado: (2016)

Life after patch testing: Allergic contact dermatitis caused by propylene glycol in Vivelle transdermal estradiol patch
por: Kaur, Gurbani, et al.
Publicado: (2021)

Castration for Hypertrophy of the Prostate Gland
Publicado: (1895)

Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxib
por: WANG, HUAQIAN, et al.
Publicado: (2014)

The Estradiol-Dihydrotestosterone model of prostate cancer
por: Friedman, A Edward
Publicado: (2005)

Advances in hormonal therapies for hormone naïve and castration-resistant prostate cancers with or without previous chemotherapy
por: Pham, Thy, et al.
Publicado: (2016)

Enzalutamide in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Asian Multiregional, Randomized Study
por: Pu, Yeong-Shiau, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jo0h389nhjul4bmfl22r4b2jrd